FDA Submits Collection of Information for OMB Review

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, which will require adverse experience reporting for licensed biological products and general records.